HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Héctor González-Pacheco Selected Research

Atherosclerosis

2/2015Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Héctor González-Pacheco Research Topics

Disease

6Inflammation (Inflammations)
08/2021 - 12/2015
6Acute Coronary Syndrome
01/2021 - 01/2014
4ST Elevation Myocardial Infarction
01/2022 - 10/2011
4Heart Failure
01/2021 - 01/2017
4Reperfusion Injury
01/2018 - 01/2014
3Myocardial Infarction
01/2022 - 03/2014
3COVID-19
01/2022 - 01/2020
3Thrombosis (Thrombus)
01/2022 - 06/2021
3Body Weight (Weight, Body)
12/2017 - 02/2014
2Ischemia
01/2021 - 01/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 01/2012
2Mitochondrial Diseases (Mitochondrial Disease)
06/2015 - 02/2014
2Infarction (Infarctions)
01/2014 - 02/2002
1Pulmonary Embolism
01/2022
1Obesity
08/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2021
1Left Ventricular Dysfunction
01/2021
1Lactic Acidosis
01/2021
1Critical Illness (Critically Ill)
01/2021
1Angina Pectoris
01/2021
1Brain Ischemia (Cerebral Ischemia)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Insulin Resistance
02/2016
1Weight Loss (Weight Reduction)
02/2016
1Overweight
02/2016
1Hyperthyroidism
06/2015
1Atherosclerosis
02/2015
1Acute Aortic Syndrome
12/2014
1Hemorrhage
03/2014
1Pathologic Constriction (Stenosis)
01/2014
1Coronary Disease (Coronary Heart Disease)
01/2014
1Dyslipidemias (Dyslipidemia)
01/2014
1Hypoxia (Hypoxemia)
01/2014
1Hyperhomocysteinemia
01/2012

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
06/2021 - 02/2015
5HDL CholesterolIBA
01/2021 - 01/2014
5Cytidine Diphosphate Choline (Citicoline)IBA
01/2018 - 01/2014
3C-Reactive ProteinIBA
08/2021 - 01/2019
3AlbuminsIBA
08/2021 - 01/2017
3LipidsIBA
02/2016 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2021
2Serum AlbuminIBA
01/2019 - 01/2017
1TroponinIBA
06/2021
1SubtilisinIBA
01/2021
1Transaminases (Aminotransferases)IBA
01/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1lipoxin A4IBA
01/2021
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1Spironolactone (Aldactone)FDA LinkGeneric
01/2021
1CytokinesIBA
01/2018
1high density lipoprotein sphingomyelinIBA
02/2016
1NucleotidesIBA
06/2015
1Triiodothyronine (Liothyronine)FDA LinkGeneric
06/2015
1acivicin (AT 125)IBA
06/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2012
1Lipoprotein(a)IBA
01/2012
1HomocysteineIBA
01/2012

Therapy/Procedure

12Therapeutics
01/2022 - 02/2002
3Percutaneous Coronary Intervention
01/2020 - 02/2002
2Artificial Respiration (Mechanical Ventilation)
08/2021 - 06/2021
2Length of Stay
08/2021 - 01/2017
2Thrombolytic Therapy
01/2020 - 02/2002
1Myocardial Revascularization
01/2021
1Endovascular Aneurysm Repair
12/2014